Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SI-614 in Patients With Dry Eye
NCT01558999Phase 2Completed
- Sponsor
- Seikagaku Corporation
- Start
- Mar 2012
- Primary completion
- Jul 2012
- Modality
- Polymer-based Nanoparticles
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cinhyaluronate sodium in dry eye syndrome (DED) (3 arms), sponsored by Seikagaku Corporation. Primary endpoints: Tear Film Break-Up Time at Day 27 and Symptom Score at Day 27. Started Mar 2012; status: completed.
02
Drugs
cinhyaluronate sodium
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT01558999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01558999.